1. Home
  2. Analysis

Hepatitis cholestatic and drugs of ingredients of enzalutamide (a real world drug study)


Summary:

Hepatitis cholestatic is found among people who take drugs with ingredients of enzalutamide, especially for people who are male, 60+ old , have been taking the drugs for 6 - 12 months. This phase IV clinical study is created by eHealthMe based on reports of 65,354 people who have side effects when taking drugs with ingredients of enzalutamide from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Enzalutamide, Xtandi.

On Jul, 31, 2026

65,354 people reported to have side effects when taking drugs with ingredients of enzalutamide.
Among them, 12 people (0.02%) have Hepatitis cholestatic

What is Hepatitis cholestatic?

Hepatitis cholestatic (flow of bile from the liver is slowed or blocked) is found to be associated with 544 drugs and 824 conditions by eHealthMe. Check the latest studies of Hepatitis cholestatic.

Number of reports submitted per year:

Could drugs with ingredients of enzalutamide cause Hepatitis cholestatic?

Time on drugs with ingredients of enzalutamide when people have Hepatitis cholestatic *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 11.11 %
  • 6 - 12 months: 88.89 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hepatitis cholestatic when taking drugs with ingredients of enzalutamide *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Hepatitis cholestatic when taking drugs with ingredients of enzalutamide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Prostate Cancer: 11 people, 91.67%
  2. High Blood Pressure: 8 people, 66.67%
  3. Diabetes: 8 people, 66.67%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
  5. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 1 person, 8.33%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Docetaxel: 8 people, 66.67%
  2. Amlodipine: 8 people, 66.67%
  3. Prednisone: 7 people, 58.33%
  4. Jevtana: 3 people, 25.00%
  5. Zoladex: 1 person, 8.33%

Other side effects people have besides Hepatitis cholestatic *:

You may use this to check any potential undetected side effects.

  1. Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 3 people, 25.00%
  2. Hepatic Enzyme Increased: 3 people, 25.00%
  3. Ascites (accumulation of fluid in the abdominal cavity): 3 people, 25.00%
  4. Acute Hepatic Failure: 3 people, 25.00%
  5. Nausea (feeling of having an urge to vomit): 1 person, 8.33%
  6. Hepatitis (inflammation of the liver): 1 person, 8.33%
  7. General Physical Health Deterioration (weak health status): 1 person, 8.33%
  8. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of enzalutamide, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on enzalutamide. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.